A Worldwide Epidemic: The Problem and Challenges of Preterm Birth in Low- and Middle-Income Countries

American Journal of Perinatology

Volumn 33, Issue 3, 2016, Pages 276-289

  Smid, Marcela C ^a   Stringer, Elizabeth M ^a   Stringer, Jeffrey S A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

global health; low and middle income countries; prematurity; preterm birth

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; MAGNESIUM; MEDROXYPROGESTERONE ACETATE; ANTIRETROVIRUS AGENT;

DEPRESSION; DISABILITY; EPIDEMIC; ETHNIC DIFFERENCE; HEALTH CARE ACCESS; HUMAN; INFECTION; LOW AND MIDDLE INCOME COUNTRY; LOWEST INCOME GROUP; NEUROPROTECTION; NEWBORN PERIOD; NUTRITION; POPULATION; POVERTY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING CESSATION; SOCIAL STATUS; TOCOLYSIS; UTERINE CERVIX CERCLAGE; VAGINA PESSARY; COMPLICATION; DEVELOPING COUNTRY; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; INFANT; INFANT MORTALITY; MATERNAL NUTRITION; NEWBORN; OBSTETRIC LABOR, PREMATURE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; DEVELOPING COUNTRIES; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; POVERTY; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84959149778     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1571199     Document Type: Review

References (210)

1. World Health Organization Born Too Soon: The Global Action Report on Preterm Birth. 2012
2. Beck S., Wojdyla D., Say L., et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ: 2010; 88 1 31 38
3. Lawn J. E., Gravett M. G., Nunes T. M., Rubens C. E., Stanton C.; GAPPS Review Group. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth: 2010; 10 01 S1
4. Blencowe H., Cousens S., Oestergaard M. Z., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet: 2012; 379 9832 2162 2172
5. World Health Organization WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand: 1977; 56 3 247 253
6. Steer P. The epidemiology of preterm labour. BJOG: 2005; 112 01 1 3
7. Goldenberg R. L., Culhane J. F., Iams J. D., Romero R. Epidemiology and causes of preterm birth. Lancet: 2008; 371 9606 75 84
8. McClure E. M., Wright L. L., Goldenberg R. L., et al. NICHD FIRST BREATH Study Group. The global network: a prospective study of stillbirths in developing countries. Am J Obstet Gynecol: 2007; 197 3 247.e1 247.e5
9. Cousens S., Blencowe H., Stanton C., et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet: 2011; 377 9774 1319 1330
10. Geerts L., Poggenpoel E., Theron G. A comparison of pregnancy dating methods commonly used in South Africa: a prospective study. S Afr Med J: 2013; 103 8 552 556
11. Bengtson A. WD, Musonda P., Pettifor A., et al. Multiple overimputation to address missing data and measurement error in gestational age: application to duration of HIV treatment before delivery and pregnancy outcomes. Epidemiology: 2015;. In press
12. WHO, UNICEF Low Birthweight: Country, Regional and Global Estimates: New York,: 2004
13. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet: 2006; 367 9524 1747 1757
14. Lee A. C., Katz J., Blencowe H., et al. CHERG SGA-Preterm Birth Working Group. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health: 2013; 1 1 e26 e36
15. Villar J., Cheikh Ismail L., Victora C. G., et al. International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet: 2014; 384 9946 857 868
16. Rosenberg R. E., Ahmed A. S., Ahmed S., et al. Determining gestational age in a low-resource setting: validity of last menstrual period. J Health Popul Nutr: 2009; 27 3 332 338
17. Villar J., Papageorghiou A. T., Knight H. E., et al. The preterm birth syndrome: a prototype phenotypic classification. Am J Obstet Gynecol: 2012; 206 2 119 123
18. Barros F. C., Papageorghiou A. T., Victora C. G., et al. International Fetal and Newborn Growth Consortium for the 21st Century. The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr: 2015; 169 3 220 229
19. Shulman C. E., Dorman E. K. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg: 2003; 97 1 30 35
20. Kulmala T., Vaahtera M., Ndekha M., et al. The importance of preterm births for peri- and neonatal mortality in rural Malawi. Paediatr Perinat Epidemiol: 2000; 14 3 219 226
21. Vogel J. P., Lee A. C., Souza J. P. Maternal morbidity and preterm birth in 22 low- and middle-income countries: a secondary analysis of the WHO Global Survey dataset. BMC Pregnancy Childbirth: 2014; 14 56
22. van den Broek N. R., Jean-Baptiste R., Neilson J. P. Factors associated with preterm, early preterm and late preterm birth in Malawi. PLoS ONE: 2014; 9 3 e90128
23. Feresu S. A., Harlow S. D., Woelk G. B. Risk factors for low birthweight in Zimbabwean women: a secondary data analysis. PLoS ONE: 2015; 10 6 e0129705
24. Fitri L. E., Jahja N. E., Huwae I. R., Nara M. B., Berens-Riha N. Congenital malaria in newborns selected for low birth-weight, anemia, and other possible symptoms in Maumere, Indonesia. Korean J Parasitol: 2014; 52 6 639 644
25. Singh J., Soni D., Mishra D., Singh H. P., Bijesh S. Placental and neonatal outcome in maternal malaria. Indian Pediatr: 2014; 51 4 285 288
26. Stanisic D. I., Moore K. A., Baiwog F., et al. Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea. Trans R Soc Trop Med Hyg: 2015; 109 5 313 324
27. Steer P. The epidemiology of preterm labor-a global perspective. J Perinat Med: 2005; 33 4 273 276
28. Qin J., Yang T., Xiao S., Tan H., Feng T., Fu H. Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis. PLoS ONE: 2014; 9 7 e102203
29. World Health Organization Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access. Progress Report 2011. Geneva: WHO; 2011. Available at: whqlibdocwhoint/publications/2011/9789241502986-engpdf. Accessed January 26, 2014
30. Gomez G. B., Kamb M. L., Newman L. M., Mark J., Broutet N., Hawkes S. J. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ: 2013; 91 3 217 226
31. Asuquo B., Vellore A. D., Walters G., Manney S., Mignini L., Kunst H. A case-control study of the risk of adverse perinatal outcomes due to tuberculosis during pregnancy. J Obstet Gynaecol: 2012; 32 7 635 638
32. Figueroa-Damián R., Arredondo-García J. L. Neonatal outcome of children born to women with tuberculosis. Arch Med Res: 2001; 32 1 66 69
33. Jana N., Vasishta K., Jindal S. K., Khunnu B., Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet: 1994; 44 2 119 124
34. Lin H. C., Lin H. C., Chen S. F. Increased risk of low birthweight and small for gestational age infants among women with tuberculosis. BJOG: 2010; 117 5 585 590
35. Klufio C. A., Amoa A. B., Delamare O., Hombhanje M., Kariwiga G., Igo J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. P N G Med J: 1995; 38 3 163 171
36. Demba E., Morison L., van der Loeff M. S., et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis: 2005; 5 12
37. Kharsany A. B., Hoosen A. A., Moodley J. Bacterial vaginosis and lower genital tract infections in women attending out-patient clinics at a tertiary institution serving a developing community. J Obstet Gynaecol: 1997; 17 2 171 175
38. Purwar M., Ughade S., Bhagat B., Agarwal V., Kulkarni H. Bacterial vaginosis in early pregnancy and adverse pregnancy outcome. J Obstet Gynaecol Res: 2001; 27 4 175 181
39. Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol: 2003; 189 1 139 147
40. Mayaud P., Uledi E., Cornelissen J., et al. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect: 1998; 74 01 S139 S146
41. Gray R. H., Wabwire-Mangen F., Kigozi G., et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol: 2001; 185 5 1209 1217
42. Riduan J. M., Hillier S. L., Utomo B., Wiknjosastro G., Linnan M., Kandun N. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol: 1993; 169 1 175 178
43. Brocklehurst P., Gordon A., Heatley E., Milan S. J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev: 2013; 1 CD000262
44. Sharma R., Maimanuku L. R., Morse Z., Pack A. R. Preterm low birth weights associated with periodontal disease in the Fiji Islands. Int Dent J: 2007; 57 4 257 260
45. Baskaradoss J. K., Geevarghese A., Kutty V. R. Maternal periodontal status and preterm delivery: a hospital based case-control study. J Periodontal Res: 2011; 46 5 542 549
46. Mumghamba E. G., Manji K. P. Maternal oral health status and preterm low birth weight at Muhimbili National Hospital, Tanzania: a case-control study. BMC Oral Health: 2007; 7 8
47. Lohsoonthorn V., Kungsadalpipob K., Chanchareonsook P., et al. Is maternal periodontal disease a risk factor for preterm delivery? Am J Epidemiol: 2009; 169 6 731 739
48. Horton A. L., Boggess K. A. Periodontal disease and preterm birth. Obstet Gynecol Clin North Am: 2012; 39 1 17 23, vii
49. Horton A. L., Boggess K. A., Moss K. L., Jared H. L., Beck J., Offenbacher S. Periodontal disease early in pregnancy is associated with maternal systemic inflammation among African American women. J Periodontol: 2008; 79 7 1127 1132
50. Jeffcoat M., Parry S., Sammel M., Clothier B., Catlin A., Macones G. Periodontal infection and preterm birth: successful periodontal therapy reduces the risk of preterm birth. BJOG: 2011; 118 2 250 256
51. Michalowicz B. S., Hodges J. S., DiAngelis A. J., et al. OPT Study. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med: 2006; 355 18 1885 1894
52. Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report: UNAIDS report on the global AIDS epidemic. 2013;. Available at: http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport [accessed December 6, 2014]
53. Finucane M. M., Stevens G. A., Cowan M. J., et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet: 2011; 377 9765 557 567
54. Aebi-Popp K., Lapaire O., Glass T. R., et al. Swiss Mother And Child HIV Cohort Study. Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008. J Perinat Med: 2010; 38 4 353 358
55. Turner A. N., Tabbah S., Mwapasa V., et al. Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study. J Acquir Immune Defic Syndr: 2013; 64 4 392 399
56. Lopez M., Figueras F., Hernandez S., et al. Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS: 2012; 26 1 37 43
57. Bansil P., Jamieson D. J., Posner S. F., Kourtis A. P. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART). J Womens Health (Larchmt): 2007; 16 2 159 162
58. Habib N. A., Daltveit A. K., Bergsjo P., Shao J., Oneko O., Lie R. T. Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG: 2008; 115 5 616 624
59. Stratton P., Tuomala R. E., Abboud R., et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol: 1999; 20 2 179 186
60. Slyker J. A., Patterson J., Ambler G., et al. Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants. BMC Pregnancy Childbirth: 2014; 14 7
61. Salihu H. M., Mogos M. F., August E. M., et al. HIV infection and its impact on fetal outcomes among women of advanced maternal age: a propensity score weighted matching approach. AIDS Res Hum Retroviruses: 2013; 29 3 581 587
62. Pattinson R. C., Hulsbergen M. H., Van Hoorick L. The effect of maternal HIV infection on maternal conditions and perinatal deaths in southwest Tshwane. Facts Views Vis Obgyn: 2010; 2 4 227 231
63. Olagbuji B. N., Ezeanochie M. C., Ande A. B., Oboro V. O. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch Gynecol Obstet: 2010; 281 6 991 994
64. Ellis J., Williams H., Graves W., Lindsay M. K. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol: 2002; 186 5 903 906
65. Coley J. L., Msamanga G. I., Fawzi M. C., et al. The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania. BJOG: 2001; 108 11 1125 1133
66. Traisathit P., Mary J. Y., Le Coeur S., et al. Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV. J Obstet Gynaecol Res: 2009; 35 2 225 233
67. Musana J. W., Ojwang S. B., Khisa W., Kiarie J. N. Pregnancy outcomes in mothers with advanced human immunodeficiency virus disease. East Afr Med J: 2009; 86 10 480 485
68. Abrams E. T., Milner D. A. Jr, Kwiek J., et al. Risk factors and mechanisms of preterm delivery in Malawi. Am J Reprod Immunol: 2004; 52 2 174 183
69. Chen J. Y., Ribaudo H. J., Souda S., et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis: 2012; 206 11 1695 1705
70. Azria E., Moutafoff C., Schmitz T., et al. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen. Antivir Ther: 2009; 14 3 423 432
71. Boer K., Nellen J. F., Patel D., et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG: 2007; 114 2 148 155
72. Ezechi O. C., Gab-Okafor C. V., Oladele D. A., et al. Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. Afr J Reprod Health: 2013; 17 3 160 168
73. Lopez M., Figueras F., Hernandez S., et al. Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS: 2012; 26 1 37 43
74. Haeri S., Shauer M., Dale M., et al. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Am J Obstet Gynecol: 2009; 201 3 315.e1 315.e5
75. Parekh N., Ribaudo H., Souda S., et al. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. Int J Gynaecol Obstet: 2011; 115 1 20 25
76. Kourtis A. P., Bansil P., McPheeters M., Meikle S. F., Posner S. F., Jamieson D. J. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. AIDS: 2006; 20 14 1823 1831
77. Rudin C., Spaenhauer A., Keiser O., et al. Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV). Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data. HIV Med: 2011; 12 4 228 235
78. Patil S., Bhosale R., Sambarey P., et al. Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India. AIDS Care: 2011; 23 12 1562 1569
79. Onah H. E., Obi S. N., Agbata T. A., Oguanuo T. C. Pregnancy outcome in HIV-positive women in Enugu, Nigeria. J Obstet Gynaecol: 2007; 27 3 271 274
80. Ndirangu J., Newell M. L., Bland R. M., Thorne C. Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod: 2012; 27 6 1846 1856
81. da Costa T. P., Leal M. C., Mota J. C., et al. Comparison of pregnancy characteristics and outcomes between HIV-infected and HIV-non-infected women in Brazil. AIDS Care: 2013; 25 6 686 690
82. HIV/AIDS JUNPo Financial Resources Required to Achieve Universal Access to HIV Prevention, Treatment, Care and Support. Geneva World Health Organization: 2007
83. Lorenzi P., Spicher V. M., Laubereau B., et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS: 1998; 12 18 F241 F247
84. van der Merwe K., Hoffman R., Black V., Chersich M., Coovadia A., Rees H. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc: 2011; 14 42
85. Martin F., Taylor G. P. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. J Infect Dis: 2007; 196 4 558 561
86. Darak S., Darak T., Kulkarni S., et al. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India. AIDS Patient Care STDS: 2013; 27 3 163 170
87. European Collaborative Study; Swiss Mother and Child HIV Cohort Study Combination antiretroviral therapy and duration of pregnancy. AIDS: 2000; 14 18 2913 2920
88. Sibiude J., Warszawski J., Tubiana R., et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis: 2012; 54 9 1348 1360
89. Townsend C. L., Cortina-Borja M., Peckham C. S., Tookey P. A. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS: 2007; 21 8 1019 1026
90. Machado E. S., Hofer C. B., Costa T. T., et al. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception. Sex Transm Infect: 2009; 85 2 82 87
91. Thorne C., Patel D., Newell M. L. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS: 2004; 18 17 2337 2339
92. Kourtis A. P., Fowler M. G. Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis: 2011; 204 4 493 494
93. Short C-ES, Taylor G. P. Antiretroviral therapy and preterm birth in HIV-infected women. Expert Rev Anti Infect Ther: 2014; 12 3 293 306
94. Kourtis A. P., Schmid C. H., Jamieson D. J., Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS: 2007; 21 5 607 615
95. Powis K. M., Kitch D., Ogwu A., et al. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis: 2011; 204 4 506 514
96. Koss C. A., Natureeba P., Plenty A., et al. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr: 2014; 67 2 128 135
97. Schutte M. F., Treffers P. E., Koppe J. G., Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. Br J Obstet Gynaecol: 1980; 87 2 127 131
98. Papiernik E., Cohen H., Richard A., de Oca M. M., Feingold J. Ethnic difference in duration of pregnancy. Ann Hum Biol: 1986; 13 3 259 265
99. Patel R. R., Steer P., Doyle P., Little M. P., Elliott P. Does gestation vary by ethnic group? A London-based study of over 122,000 pregnancies with spontaneous onset of labour. Int J Epidemiol: 2004; 33 1 107 113
100. Olowe S. A., Akinkugbe A. Amniotic fluid lecithin/sphingomyelin ratio: comparison between an African and North American community. Pediatrics: 1978; 62 1 38 41
101. Papiernik E., Alexander G. R., Paneth N. Racial differences in pregnancy duration and its implications for perinatal care. Med Hypotheses: 1990; 33 3 181 186
102. Torloni M. R., Betrán A. P., Daher S., et al. Maternal BMI and preterm birth: a systematic review of the literature with meta-analysis. J Matern Fetal Neonatal Med: 2009; 22 11 957 970
103. Kanadys W. M., Leszczyńska-Gorzelak B., Jedrych M., Oleszczuk J. Maternal pre-pregnancy obesity and the risk of preterm birth: a systematic overview of cohort studies with meta-analysis [in Polish]. Ginekol Pol: 2012; 83 4 270 279
104. Parker M. G., Ouyang F., Pearson C., et al. Prepregnancy body mass index and risk of preterm birth: association heterogeneity by preterm subgroups. BMC Pregnancy Childbirth: 2014; 14 153
105. McLean E., Cogswell M., Egli I., Wojdyla D., de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993-2005. Public Health Nutr: 2009; 12 4 444 454
106. Stevens G. A., Finucane M. M., De-Regil L. M., et al. Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health: 2013; 1 1 e16 e25
107. Scholl T. O., Hediger M. L. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr: 1994; 59 (2, Suppl): 492S 500S, discussion 500S-501S
108. Scholl T. O., Hediger M. L., Fischer R. L., Shearer J. W. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr: 1992; 55 5 985 988
109. Klebanoff M. A., Shiono P. H., Selby J. V., Trachtenberg A. I., Graubard B. I. Anemia and spontaneous preterm birth. Am J Obstet Gynecol: 1991; 164 (1, Pt 1): 59 63
110. Osendarp S. J., West C. E., Black R. E.; Maternal Zinc Supplementation Study Group. The need for maternal zinc supplementation in developing countries: an unresolved issue. J Nutr: 2003; 133 3 817S 827S
111. Ngoc N. T., Merialdi M., Abdel-Aleem H., et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ: 2006; 84 9 699 705
112. Ratzon R., Sheiner E., Shoham-Vardi I. The role of prenatal care in recurrent preterm birth. Eur J Obstet Gynecol Reprod Biol: 2011; 154 1 40 44
113. Cecatti J. G., Correa-Silva E. P., Milanez H., Morais S. S., Souza J. P. The associations between inter-pregnancy interval and maternal and neonatal outcomes in Brazil. Matern Child Health J: 2008; 12 2 275 281
114. Conde-Agudelo A., Belizán J. M. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ: 2000; 321 7271 1255 1259
115. Shah N. R., Bracken M. B. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol: 2000; 182 2 465 472
116. Glynn T., Seffrin J. R., Brawley O. W., Grey N., Ross H. The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin: 2010; 60 1 50 61
117. Amos A., Greaves L., Nichter M., Bloch M. Women and tobacco: a call for including gender in tobacco control research, policy and practice. Tob Control: 2012; 21 2 236 243
118. Boy E., Bruce N., Delgado H. Birth weight and exposure to kitchen wood smoke during pregnancy in rural Guatemala. Environ Health Perspect: 2002; 110 1 109 114
119. Bruce N., Perez-Padilla R., Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ: 2000; 78 9 1078 1092
120. Pope D. P., Mishra V., Thompson L., et al. Risk of low birth weight and stillbirth associated with indoor air pollution from solid fuel use in developing countries. Epidemiol Rev: 2010; 32 70 81
121. Grote N. K., Bridge J. A., Gavin A. R., Melville J. L., Iyengar S., Katon W. J. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry: 2010; 67 10 1012 1024
122. Patel V., Rahman A., Jacob K. S., Hughes M. Effect of maternal mental health on infant growth in low income countries: new evidence from South Asia. BMJ: 2004; 328 7443 820 823
123. Rahman A., Iqbal Z., Harrington R. Life events, social support and depression in childbirth: perspectives from a rural community in the developing world. Psychol Med: 2003; 33 7 1161 1167
124. Stringer E. M., Meltzer-Brody S., Kasaro M., et al. Depression, pregnancy, and HIV: the case to strengthen mental health services for pregnant and post-partum women in sub-Saharan Africa. Lancet Psychiatry: 2014; 1 2 159 162
125. Meltzer-Brody S., Stringer E. M. Global maternal, newborn, and child health. N Engl J Med: 2014; 370 11 1072
126. Spong C. Y., Mercer B. M., D'alton M., Kilpatrick S., Blackwell S., Saade G. Timing of indicated late-preterm and early-term birth. Obstet Gynecol: 2011; 118 (2, Pt 1): 323 333
127. Tita A. T., Landon M. B., Spong C. Y., et al. Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med: 2009; 360 2 111 120
128. De Luca R., Boulvain M., Irion O., Berner M., Pfister R. E. Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery. Pediatrics: 2009; 123 6 e1064 e1071
129. Vogel J. P., Souza J. P., Gülmezoglu A. M. Patterns and outcomes of induction of labour in Africa and Asia: a secondary analysis of the WHO Global Survey on Maternal and Neonatal Health. PLoS ONE: 2013; 8 6 e65612
130. Villar J., Valladares E., Wojdyla D., et al. WHO 2005 global survey on maternal and perinatal health research group. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet: 2006; 367 9525 1819 1829
131. Lumbiganon P., Laopaiboon M., Gülmezoglu A. M., et al. World Health Organization Global Survey on Maternal and Perinatal Health Research Group. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08. Lancet: 2010; 375 9713 490 499
132. Victora C. G., Rubens C. E.; GAPPS Review Group. Global report on preterm birth and stillbirth (4 of 7): delivery of interventions. BMC Pregnancy Childbirth: 2010; 10 01 S4
133. Owusu-Edusei K. Jr, Gift T. L., Ballard R. C. Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa. Sex Transm Dis: 2011; 38 11 997 1003
134. Rydzak C. E., Goldie S. J. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis: 2008; 35 9 775 784
135. Sangkomkamhang U. S., Lumbiganon P., Prasertcharoensuk W., Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev: 2015; 2 CD006178
136. Luntamo M., Kulmala T., Mbewe B., Cheung Y. B., Maleta K., Ashorn P. Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. Am J Trop Med Hyg: 2010; 83 6 1212 1220
137. Haider B. A., Olofin I., Wang M., Spiegelman D., Ezzati M., Fawzi W. W.; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ: 2013; 346 f3443
138. Imdad A., Bhutta Z. A. Nutritional management of the low birth weight/preterm infant in community settings: a perspective from the developing world. J Pediatr: 2013; 162 (3, Suppl): S107 S114
139. Lassi Z. S., Salam R. A., Haider B. A., Bhutta Z. A. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev: 2013; 3 CD006896
140. Peña-Rosas J. P., De-Regil L. M., Garcia-Casal M. N., Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev: 2015; 7 CD004736
141. van Eijk A. M., De Cock K. M., Ayisi J. G., et al. Pregnancy interval and delivery outcome among HIV-seropositive and HIV-seronegative women in Kisumu, Kenya. Trop Med Int Health: 2004; 9 1 15 24
142. Barros F. C., Bhutta Z. A., Batra M., Hansen T. N., Victora C. G., Rubens C. E.; GAPPS Review Group. Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions. BMC Pregnancy Childbirth: 2010; 10 01 S3
143. Barros F. C., Victora C. G., Barros A. J., et al. The challenge of reducing neonatal mortality in middle-income countries: findings from three Brazilian birth cohorts in 1982, 1993, and 2004. Lancet: 2005; 365 9462 847 854
144. Iams J. D., Romero R., Culhane J. F., Goldenberg R. L. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet: 2008; 371 9607 164 175
145. Lumley J., Chamberlain C., Dowswell T., Oliver S., Oakley L., Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev: 2009; 3 CD001055
146. Meis P. J., Klebanoff M., Thom E., et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med: 2003; 348 24 2379 2385
147. Committee on Practice Bulletins-Obstetrics, The American College of Obstetricians and Gynecologists Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol: 2012; 120 4 964 973
148. Jabeen S., Akhtar M., Fatima N. Role of progesterone for the prevention of preterm labor. Pak J Med Sci: 2012; (Jan-Mar)
149. Khan F. K., Intsar A., Khurshid S. Prevention of recurrent preterm delivery by 17 alpha hydroxyl progesterone caproate. Biomedica: 2013; 29 92
150. da Fonseca E. B., Bittar R. E., Carvalho M. H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol: 2003; 188 2 419 424
151. Hassan S. S., Romero R., Vidyadhari D., et al. PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol: 2011; 38 1 18 31
152. Romero R., Nicolaides K., Conde-Agudelo A., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol: 2012; 206 2 124.e1 124.e19
153. Cetingoz E., Cam C., Sakalll M., Karateke A., Celik C., Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet: 2011; 283 3 423 429
154. O'Brien J. M., Adair C. D., Lewis D. F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol: 2007; 30 5 687 696
155. Many in VOICE trial didn't use provided prevention products. AIDS Policy Law: 2015; 30 4 3
156. Friedman A. M., Schwartz N., Ludmir J., Parry S., Bastek J. A., Sehdev H. M. Can transabdominal ultrasound identify women at high risk for short cervical length? Acta Obstet Gynecol Scand: 2013; 92 6 637 641
157. Friedman A. M., Srinivas S. K., Parry S., Elovitz M. A., Wang E., Schwartz N. Can transabdominal ultrasound be used as a screening test for short cervical length? Am J Obstet Gynecol: 2013; 208 3 190.e1 190.e7
158. Abdel-Aleem H., Shaaban O. M., Abdel-Aleem M. A. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev: 2013; 5 CD007873
159. Alfirevic Z., Stampalija T., Roberts D., Jorgensen A. L. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev: 2012; 4 CD008991
160. American College of Obstetricians and Gynecologists ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstet Gynecol: 2014; 123 (2, Pt 1): 372 379
161. Odibo A. O., Elkousy M., Ural S. H., Macones G. A. Prevention of preterm birth by cervical cerclage compared with expectant management: a systematic review. Obstet Gynecol Surv: 2003; 58 2 130 136
162. Owen J., Hankins G., Iams J. D., et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol: 2009; 201 4 375.e1 375.e8
163. Rafael T. J., Berghella V., Alfirevic Z. Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy. Cochrane Database Syst Rev: 2014; 9 CD009166
164. MRC/RCOG Working Party on Cervical Cerclage Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol: 1993; 100 6 516 523
165. Egwuatu V. E. Complications of cervical cerclage in Igbo women. J Natl Med Assoc: 1986; 78 3 245 246
166. World Health Organization WHO Recommendations on Interventions to Improve Preterm Birth Outcomes. 2015
167. Liggins G. C., Howie R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics: 1972; 50 4 515 525
168. Block M. F., Kling O. R., Crosby W. M. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstet Gynecol: 1977; 50 2 186 190
169. Amorim M. M., Santos L. C., Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol: 1999; 180 5 1283 1288
170. Doran T. A., Swyer P., MacMurray B., et al. Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. Am J Obstet Gynecol: 1980; 136 3 313 320
171. Fekih M., Chaieb A., Sboui H., Denguezli W., Hidar S., Khairi H. Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study [in French]. Tunis Med: 2002; 80 5 260 265
172. Gamsu H. R., Mullinger B. M., Donnai P., Dash C. H. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. Br J Obstet Gynaecol: 1989; 96 4 401 410
173. Garite T. J., Rumney P. J., Briggs G. G., et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol: 1992; 166 2 646 651
174. Lewis D. F., Brody K., Edwards M. S., Brouillette R. M., Burlison S., London S. N. Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics. Obstet Gynecol: 1996; 88 5 801 805
175. Morales W. J., Angel J. L., O'Brien W. F., Knuppel R. A. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol: 1989; 73 (5, Pt 1): 721 726
176. Nelson L. H., Meis P. J., Hatjis C. G., Ernest J. M., Dillard R., Schey H. M. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol: 1985; 66 1 55 58
177. Qublan H. S., Malkawi H. Y., Hiasat M. S., et al. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes. Clin Exp Obstet Gynecol: 2001; 28 3 183 186
178. Taeusch H. W. Jr, Frigoletto F., Kitzmiller J., et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics: 1979; 63 1 64 72
179. Pattinson R. C., Makin J. D., Funk M., et al. Dexiprom Study Group. The use of dexamethasone in women with preterm premature rupture of membranes-a multicentre, double-blind, placebo-controlled, randomised trial. S Afr Med J: 1999; 89 8 865 870
180. Eronen M., Kari A., Pesonen E., Hallman M. The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study. Am J Dis Child: 1993; 147 2 187 192
181. Teramo K., Hallman M., Raivio K. O. Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant. Pediatr Res: 1980; 14 (4, Pt 1): 326 329
182. Silver R. K., Vyskocil C., Solomon S. L., Ragin A., Neerhof M. G., Farrell E. E. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation. Obstet Gynecol: 1996; 87 (5, Pt 1): 683 691
183. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev: 2006; 3 CD004454
184. Committee on Obstetric Practice ACOG committee opinion. Antenatal corticosteroid therapy for fetal maturation American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet: 2002; 78 1 95 97
185. Mwansa-Kambafwile J., Cousens S., Hansen T., Lawn J. E. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol: 2010; 39 01 i122 i133
186. Vogel J. P., Souza J. P., Gülmezoglu A. M., et al. WHO Multi-Country Survey on Maternal and Newborn Health Research Network. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet: 2014; 384 9957 1869 1877
187. Althabe F., Belizán J. M., McClure E. M., et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet: 2015; 385 9968 629 639
188. van Stralen G., van der Bos J., Lopriore E., et al. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study. Early Hum Dev: 2009; 85 4 253 257
189. Torrance H. L., Derks J. B., Scherjon S. A., Wijnberger L. D., Visser G. H. Is antenatal steroid treatment effective in preterm IUGR fetuses? Acta Obstet Gynecol Scand: 2009; 88 10 1068 1073
190. Adams M. M., Elam-Evans L. D., Wilson H. G., Gilbertz D. A. Rates of and factors associated with recurrence of preterm delivery. JAMA: 2000; 283 12 1591 1596
191. Kenyon S., Boulvain M., Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev: 2003; 2 CD001058
192. Cousens S., Blencowe H., Gravett M., Lawn J. E. Antibiotics for pre-term pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection. Int J Epidemiol: 2010; 39 01 i134 i143
193. Flenady V., Hawley G., Stock O. M., Kenyon S., Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev: 2013; 12 CD000246
194. Stoll B. J., Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J: 1998; 17 6 499 503
195. Mulholland E. K., Ogunlesi O. O., Adegbola R. A., et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J: 1999; 18 (10, Suppl): S35 S41
196. Muhe L., Tilahun M., Lulseged S., et al. Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J: 1999; 18 (10, Suppl): S56 S61
197. Bomela H. N., Ballot D. E., Cooper P. A. Is prophylaxis of early-onset group B streptococcal disease appropriate for South Africa? S Afr Med J: 2001; 91 10 858 860
198. Tan K. W., Tay L., Lin R., Daniel M., Bhavani S., Lim S. H. Group B Streptococcal septicaemia/meningitis in neonates in a Singapore teaching hospital. Aust N Z J Obstet Gynaecol: 1998; 38 4 418 423
199. Kuruvilla K. A., Pillai S., Jesudason M., Jana A. K. Bacterial profile of sepsis in a neonatal unit in south India. Indian Pediatr: 1998; 35 9 851 858
200. McNamara H. C., Crowther C. A., Brown J. Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour. Cochrane Database Syst Rev: 2015; 12 CD011200
201. Flenady V., Wojcieszek A. M., Papatsonis D. N., et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev: 2014; 6 CD002255
202. Vogel J. P., Nardin J. M., Dowswell T., West H. M., Oladapo O. T. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev: 2014; 7 CD006169
203. Neilson J. P., West H. M., Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev: 2014; 2 CD004352
204. Flenady V., Wojcieszek A. M., Papatsonis D. N., et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev: 2014; 6 CD002255
205. Lawn J. E., Cousens S. N., Darmstadt G. L., et al. Lancet Neonatal Survival Series Steering Team. 1 year after The Lancet Neonatal Survival Series-was the call for action heard? Lancet: 2006; 367 9521 1541 1547
206. Lawn J. E., Mwansa-Kambafwile J., Horta B. L., Barros F. C., Cousens S. 'Kangaroo mother care' to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol: 2010; 39 01 i144 i154
207. Conde-Agudelo A., Díaz-Rossello J. L. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev: 2014; 4 CD002771
208. van den Heuvel M., Blencowe H., Mittermayer K., et al. Introduction of bubble CPAP in a teaching hospital in Malawi. Ann Trop Paediatr: 2011; 31 1 59 65
209. Murguia-Peniche T., Kirsten G. F. Meeting the challenge of providing neonatal nutritional care to very or extremely low birth weight infants in low-resource settings. World Rev Nutr Diet: 2014; 110 278 296
210. World Health Organization, UNICEF Global Strategy for Infant and Young Child Feeding. Geneva, Switzerland World Health Organization: 2003